Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Directors' Dealings

10th Jul 2014 09:10

RNS Number : 9581L
Amphion Innovations PLC
10 July 2014
 



 

Amphion Innovations plc

Directors' DealingsDirectors Receive Shares in Lieu of Fees

London and New York, 10 July 2014- Amphion Innovations plc (the "Company") (LSE: AMP), the developer of medical and technology businesses, announces that the Company has today issued 690,663 ordinary shares, representing 0.47% of the enlarged issued share capital, to certain of its Board members as their directors' fees for the fourth quarter of 2013 and the first two quarters of 2014, priced at 2.175 pence, being the average of the closing mid-market price for the five days leading up to the market close on 8 July 2014. Following this issue, the directors' shareholdings in the Company are as follows:

Director

Number of New Shares

Total Shareholding

Percentage of voting rights

R. James Macaleer

596,913

25,077,179

16.993%

Gerard Moufflet

93,750

956,250

0.648%

Director, Anthony Henfrey waived his fees for the fourth quarter of 2013 as well as for the first two quarters of 2014.

Admission of the 690,663 new ordinary shares, ranking pari passu with the existing ordinary shares, is expected on 16 July 2014. Following this allotment the total issued share capital of the Company will increase to 147,574,734 ordinary shares with each share holding one voting right.

 

For further information please contact

Amphion InnovationsCharlie Morgan+1 212 210 6224

Novella Communications Tim Robertson / Ben Heath+44 020 3151 7008

Panmure Gordon Limited Freddy Crossley / Fred Walsh (Corporate Finance)Charlie Leigh-Pemberton (Corporate Broking)+44 020 7886 2500

About Amphion Innovations plc

Amphion (LSE: AMP) builds shareholder value in emerging companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.

On the web: www.amphionplc.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSGGUMUMUPCURU

Related Shares:

AMP.L
FTSE 100 Latest
Value8,834.03
Change-41.19